AI-generated representative image NEW DELHI: NITI Aayog on Thursday unveiled an ambitious roadmap to help Ayurveda gain global recognition as a healthcare system by 2047, proposing a global practitioner registry, internationally accepted quality standards and insurance-backed treatment to move beyond its current image as a wellness product. The roadmap comes even as many Ayurvedic formulations continue to be sold as dietary supplements rather than recognised medicines in major global markets.Released by NITI Aayog Vice-Chairman Dr. Ashok Kumar Lahiri in the presence of Member (Health) Prof (Dr) M Srinivas, CEO Nidhi Chhibber and Ayush Secretary Vaidya Rajesh Kotecha, the report, Strategic Roadmap for Making Ayurveda Global, says India must move beyond exporting herbs and wellness products to building a globally trusted healthcare system backed by stronger research, regulation and international acceptance.The report notes that exports of Ayush and herbal products nearly doubled from USD 1.09 billion in 2014 to USD 2.16 billion in 2023, with Ayurveda products reaching around 150 countries. Yet regulatory barriers continue to keep many Ayurvedic formulations out of mainstream healthcare systems in developed markets, where they are largely sold as dietary supplements instead of approved medicines.While Ayurveda has gained varying degrees of recognition in nearly 30 countries and research is underway in almost 70 countries, India has yet to build a sizable global workforce. The report says the country has over 3.55 lakh trained Ayurveda practitioners, but nearly 95% of them are based in India because of the absence of internationally accepted licensing systems and limited professional mobility.To address these gaps, the roadmap recommends creating a Global Ayurveda Register with internationally verifiable credentials, a single-window portal carrying country-specific licensing requirements and visa information, and mutual recognition agreements with partner countries to enable qualified Indian practitioners to work overseas.To improve global acceptance, the report calls for expanding international clinical trials through WHO collaborating centres, creating real-world patient registries, publishing annual global evidence and safety reports, promoting research in emerging areas such as Ayurgenomics, upgrading domestic manufacturing to WHO-GMP standards, and publishing an export edition of the Ayurvedic Pharmacopoeia aligned with international regulatory requirements.The roadmap also proposes shifting India’s strategy from exporting raw herbs to high-value formulations, healthcare services and medical expertise. It recommends overseas Ayurveda centres, stronger regulatory support for exporters through Ayush Export Promotion Council, a real-time trade dashboard, and treatment hubs linked to Ayush visas and insurance-backed medical value travel.Drawing lessons from the global expansion of Traditional Chinese Medicine, the report calls for coordinated action across research, regulation, diplomacy, education and trade, besides setting up a high-level Mission Steering Group to steer implementation through 2047.Get the latest India news and live updates. Download the TOI App.About the AuthorAnuja JaiswalAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.Read MoreEnd of ArticleFollow Us On Social MediaVideosBengal Eyes New Industrial Era As CM Adhikari Targets FDI Growth And Manufacturing ExpansionTMC Power Battle Escalates As Ritabrata Faction Takes Over Party HQ, Stakes Claim To SymbolCentre Directs Apple, Google To Remove 7 Apps From Their Stores Over E-Rickshaw Shutdown ScareCentre To Summon Meta Over Instagram Ads Promoting Child Sexual Abuse: Report’Police Are Not Servants Of CM Or PM’: Bombay High Court Quashes SDPI Leader’s ExternmentFour Former AIADMK Ministers Switch To TVK; Fresh Political Churn Leaves Six Assembly Seats VacantKarur Stampede Flashpoint: TVK-DMK Clash; Former CM Allegedly Blamed For Loss Of LivesTwin-Flower Symbol Under Threat As EC Examines Mamata And Ritabrata Faction ClaimsRam Mandir Donation Row Deepens As Vinay Katiyar Claims Trust Officials Could Face Jail’Unfortunate, We Are All Hurt’: RSS Issues First Statement On Ayodhya Ram Temple ‘Donation Theft’123PhotostoriesWhat would you do? I found out my friends have a separate WhatsApp group without me; 5 women share what they did next60-second money lesson: The first three things to do after your salary is credited5 ingredients to mix with curry leaf oil for faster hair growthLabrador Retriever vs Golden Retriver vs Beagle: Which is best suited for families with children10 deadliest snakes in the world and where can travellers find them”I make really good Indian…” Taylor Swift reveals her love for cooking this fiber-rich vegetarian dishKangana Ranaut channels vintage femme fatale glamour in a fierce all-black look for ‘Lock Upp 2’From his bond with Dilip Joshi to watching IPL match with SRK in his vanity: When Taarak Mehta Ka Ooltah Chashmah’s Goli aka Kush Shah spoke about his journey8 traditional South Indian rice dishes for a light, healthy summer dinner (with calories)BLACKPINK’s Lisa and Tamannaah Bhatia serve Yin and Yang-inspired ensembles at the Shiseido launch event123Hot PicksTrump tariffsLuka Modric Net WorthEPF Scheme 2026Amarnath Yatra 2026Income Tax Return FilingMumbai rainUS unemploymentMicrosoft layoffsIndia Japal TradeTop TrendingBrittany MahomesTravis KelceKansas CityFIFA World Cup 2026GTA 6 Estimated SizeNew England PatriotsCandace OwensFIFA War DecisionCA Toppers ListAnitha Radhakrishnan
NEW DELHI: NITI Aayog on Thursday unveiled an ambitious roadmap to help Ayurveda gain global recognition as a healthcare system by 2047, proposing a global practitioner registry, internationally accepted quality standards and insurance-backed treatment to move beyond its current image as a wellness product. The roadmap comes even as many Ayurvedic formulations continue to be sold as dietary supplements rather than recognised medicines in major global markets.Released by NITI Aayog Vice-Chairman Dr. Ashok Kumar Lahiri in the presence of Member (Health) Prof (Dr) M Srinivas, CEO Nidhi Chhibber and Ayush Secretary Vaidya Rajesh Kotecha, the report, Strategic Roadmap for Making Ayurveda Global, says India must move beyond exporting herbs and wellness products to building a globally trusted healthcare system backed by stronger research, regulation and international acceptance.The report notes that exports of Ayush and herbal products nearly doubled from USD 1.09 billion in 2014 to USD 2.16 billion in 2023, with Ayurveda products reaching around 150 countries. Yet regulatory barriers continue to keep many Ayurvedic formulations out of mainstream healthcare systems in developed markets, where they are largely sold as dietary supplements instead of approved medicines.While Ayurveda has gained varying degrees of recognition in nearly 30 countries and research is underway in almost 70 countries, India has yet to build a sizable global workforce. The report says the country has over 3.55 lakh trained Ayurveda practitioners, but nearly 95% of them are based in India because of the absence of internationally accepted licensing systems and limited professional mobility.To address these gaps, the roadmap recommends creating a Global Ayurveda Register with internationally verifiable credentials, a single-window portal carrying country-specific licensing requirements and visa information, and mutual recognition agreements with partner countries to enable qualified Indian practitioners to work overseas.To improve global acceptance, the report calls for expanding international clinical trials through WHO collaborating centres, creating real-world patient registries, publishing annual global evidence and safety reports, promoting research in emerging areas such as Ayurgenomics, upgrading domestic manufacturing to WHO-GMP standards, and publishing an export edition of the Ayurvedic Pharmacopoeia aligned with international regulatory requirements.The roadmap also proposes shifting India’s strategy from exporting raw herbs to high-value formulations, healthcare services and medical expertise. It recommends overseas Ayurveda centres, stronger regulatory support for exporters through Ayush Export Promotion Council, a real-time trade dashboard, and treatment hubs linked to Ayush visas and insurance-backed medical value travel.Drawing lessons from the global expansion of Traditional Chinese Medicine, the report calls for coordinated action across research, regulation, diplomacy, education and trade, besides setting up a high-level Mission Steering Group to steer implementation through 2047.
